Spinal Surgical Devices: Technologies and Global Markets
November 02, 2010
Wellesley, Mass. – According to a new technical market research report, SPINAL SURGICAL DEVICES: TECHNOLOGIES AND GLOBAL MARKETS (HLC075A) from BCC Research (www.bccresearch.com), the global market for spinal surgical devices is expected to be valued at an estimated $5.5 billion in 2010, but will increase to nearly $6.5 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 3.4%.
The largest market, made up of fusion devices, is projected to reach $4.6 billion in 2015, after increasing at a CAGR of only 1.3% from its 2010 value of more than $4.3 billion.
The segment made up of non-fusion devices is estimated to be valued at $624 million in 2010, and to increase at a CAGR of 10% to reach more than $1 billion by 2015.
The vetrebral repair segment is also expected to show a CAGR 10%, increasing in value from $532 million in 2010 to $856 million in 2015.
Vertebral repair is a rapidly growing market, directly related to the continued growth of the aging population and osteoporosis-related fractures.
Fusion devices remain the gold standard of care in spinal surgery. They represent the majority of device revenue, medical expenditure, and volume of surgical procedures utilizing implanted devices by a considerable margin. The non-fusion segment represents novel technologies that have gained a slight foothold in Europe and are slowly emerging from investigational use and into the commercial market space in the U.S.
Minimally-invasive surgeries are garnering great attention as a means of improving patient recovery and reducing surgical costs associated with the treatment of spinal conditions. Specialized tools and techniques are allowing traditional surgical approaches for both fusion and non-fusion procedures to be adapted to lessen the invasiveness of treatment. Minimally-invasive options for both segments are included within the broad product categories.
The objectives of this report are to present a comprehensive analysis of the market for these orthopedic products and forecast their commercial potential through 2015.
This report is intended for anyone interested in better understanding the role of the rapidly growing spine segment of the broader orthopedic and biologic markets. Executives, consultants, trade associations, and marketing professionals in the medical device industry, health insurance industry, orthopedics and biologics fields, and ambulatory surgery and broader hospital sector would benefit from the information in this report.

Source: BCC Research
Spinal Surgical Devices: Technologies and Global Markets( HLC075A )
Publish Date: Aug 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand